Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| R-(-)-Bicalutamide and S-(+)-Bicalutamide | Oncology | LC/MS/MS | 1 - 2000 ng/mL-0.5-2000 ng/mL | Human EDTA K3 Plasma |
| R-(-)-Bicalutamide; S-(+)-Bicalutamide | Oncology | LC/MS/MS | 5-1000 ng/ml; 5-200 ng/ml | Human EDTA Plasma |
| R-(+)-Sibutramine; S-(-)-Sibutramine | Central Nervous System Agents | LC/MS/MS | 50-2000 pg/ml | Human EDTA plasma |
| R-(+)-Sibutramine; S-(-)-Sibutramine | Nervous sistem agent | LC/MS/MS | R-Sibutramine 15-7500 pg/mL; S-(-)-Sibutramine 15-3000pg/mL | HUMAN SODIUM HEPARINIZED PLASMA |
| R/S-Zopiclone (chiral method) | Central Nervous System Agents | LC/MS/MS | 1-100 ng/mL | Human EDTA Plasma |
| Rabeprazole | Gastrointestinal | LC/MS/MS | 2-1000 ng/mL | Human EDTA Plasma |
| Racecadotril | Gastrointestinal | LC/MS/MS | 10-5000 pg/mL | Human Plasma |
| Raloxifene | Rheumatology | LC/MS/MS | 10-500 pg/mL | Human EDTA Plasma |
| Raloxifene-4'-glucuronide; Raloxifene-6-glucuronide | Rheumatology | LC/MS/MS | 2 - 200 ng/mL; 0.4 - 40 ng/mL | Human EDTA Plasma |
| Raloxifene-6-glucuronide | Rheumatology | LC/MS/MS | 0.6-150 ng/ml; 0.3-75 ng/ml | Human EDTA Plasma |
| Ramipril; Ramiprilat | Cardiovascular | LC/MS/MS | 200-80000 pg/mL; 200-80000 pg/mL | Human EDTA Plasma |
| Ramipril; Ramiprilat | Cardiovascular | LC/MS/MS | 100-40000 pg/mL | Human EDTA Plasma |
| Ranitidine | Gastrointestinal | LC/MS/MS | 4-1600 ng/mL | Human EDTA Plasma |
| Rasagiline | TBD | LC/MS/MS | 50-10000 pg/mL | Human EDTA Plasma |
| Repaglinide | Endocrinology | LC/MS/MS | 0.1-50 ng/mL | Human EDTA Plasma |
| Repaglinide | Endocrinology | LC/MS/MS | 100-25000 pg/mL | Human EDTA Plasma |
| Rhein | Miscellaneous | LC/MS/MS | 50-5000 ng/mL | Human EDTA Plasma |
| Ribavirin | Infectious Disease | LC/MS/MS | 10-5000 ng/mL | Human EDTA Plasma |
| Rifampin | TBD | LC/MS/MS | 50-12500 ng/mL | Human Whole Blood |
| Rifaximin | Infectious Disease | LC/MS/MS | 50-5000 pg/mL | Human Plasma |
| Riluzole | Central Nervous System Agents | LC/MS/MS | 0.5-500 ng/mL | Human EDTA Plasma |
| Risedronic Acid | Endocrinology, Rheumatology | LC/MS/MS | 200-50000 pg/mL | Human EDTA Plasma |
| Risperidone; 9-hydroxyrisperidone | Central Nervous System Agents | LC/MS/MS | 100-30000 pg/mL ; 100-15000 pg/mL | Human EDTA Plasma |
| Risperidone; 9-hydroxyrisperidone | Central Nervous System Agents | LC/MS/MS | 100-50000 pg/mL ; 100-25000 pg/mL | Human EDTA Plasma |
| Ritalinic acid | Central Nervous System Agents | LC/MS/MS | 1-250 ng/mL | Human EDTA Plasma |
| Ritonavir | Infectious Disease | LC/MS/MS | 5-1000 ng/mL | Human EDTA Plasma |
| Rivastigmine | Central Nervous System Agents | LC/MS/MS | 100-10000 pg/mL | Human EDTA Plasma |
| Rivastigmine and metabolite | Central Nervous System Agents | LC/MS/MS | 0.2-30 ng/mL | Human EDTA K3 Plasma |
| Rizatriptan | Pain | LC/MS/MS | 100-40000 pg/mL | Human EDTA Plasma |
| Rizatriptan; N-Desmethyl Rizatrptan | Pain | LC/MS/MS | 100-40000 pg/mL;10-4000 pg/mL | Human EDTA Plasma |
| Ropinirole | Central Nervous System Agents | LC/MS/MS | 5-1000 pg/mL | Human EDTA Plasma |
| Rosiglitazone | Endocrinology | LC/MS/MS | 2-900 ng/mL | Human EDTA Plasma |
| Rosuvastatin | Cardiovascular | LC/MS/MS | 80-40000 pg/mL | Human EDTA Plasma |
| R-Selegiline | Central Nervous Agents | LC/MS/MS | 50-5000 ng/mL | Human EDTA Plasma |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine and L-Methamphetamine | Central Nervous System Agents | LC/MS/MS | 10-10000 pg/mL, 50-5000 pg/mL, 20-8000 pg/mL and 20-8000 pg/mL | Rat Plasma |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine and L-Methamphetamine | Central Nervous System Agents | LC/MS/MS | 40-8000 pg/mL, 100-20000 pg/mL, 50-20000 pg/mL and 50-20000 pg/mL | Human Urine |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine and L-Methamphetamine | Central Nervous System Agents | LC/MS/MS | 50-5000 pg/mL, 25-2500 pg/mL, 20-2500pg/mL and 15-6000 pg/mL | Human EDTA Plasma |
| R-Selegiline, N-Desmethyl Selegiline, L-Amphetamine and L-Methamphetamine | Central Nervous System Agents | LC/MS/MS | 10-10000 pg/mL, 50-5000 pg/mL, 20-8000 pg/mL and 20-8000 pg/mL | Rabbit EDTA Plasma |